Anandamide and vanilloid TRPV1 receptors - sprookjes - yvandenbroek - TriplyDB

Anandamide and vanilloid TRPV1 receptors

Anandamide and vanilloid TRPV1 receptors

http://www.wikidata.org/entity/Q24672354

about

Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation Endocannabinoids in the retina: from marijuana to neuroprotection Orphan endogenous lipids and orphan GPCRs: a good match Cannabinoid pharmacology: the first 66 years Glial Modulation by N-acylethanolamides in Brain Injury and Neurodegeneration Perspectives of TRPV1 Function on the Neurogenesis and Neural Plasticity Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis Psychiatric Disorders and TRP Channels: Focus on Psychotropic Drugs TRPV1 Channel: A Potential Drug Target for Treating Epilepsy Functionally important amino acid residues in the transient receptor potential vanilloid 1 (TRPV1) ion channel--an overview of the current mutational data A role of CB1R in inducing θ-rhythm coordination between the gustatory and gastrointestinal insula Ocular transient receptor potential channel function in health and disease.What we know and do not know about the cannabinoid receptor 2 (CB2)The endocannabinoid system: directing eating behavior and macronutrient metabolism Nociceptors in cardiovascular functions: complex interplay as a result of cyclooxygenase inhibition Polymodal activation of the endocannabinoid system in the extended amygdala TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat Identification of a high-affinity binding site involved in the transport of endocannabinoids.Anandamide induces sperm release from oviductal epithelia through nitric oxide pathway in bovines Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed TRPV1: A Potential Drug Target for Treating Various Diseases.Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.TRPA1 expression and its functional activation in rodent cortex.Anandamide potentiation of miniature spontaneous excitatory synaptic transmission is mediated via IP3 pathway.Endocannabinoid system acts as a regulator of immune homeostasis in the gut.In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability Direct Anandamide Activation of TRPV1 Produces Divergent Calcium and Current Responses.Anandamide capacitates bull spermatozoa through CB1 and TRPV1 activation Adolescent exposure to cannabis as a risk factor for psychiatric disorders.Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice.The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome.Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice The endocannabinoid system and pain Cannabidiol as potential anticancer drug.Inhibition of FAAH, TRPV1, and COX2 by NSAID-serotonin conjugates.Quantification of anandamide, oleoylethanolamide and palmitoylethanolamide in rodent brain tissue using high performance liquid chromatography-electrospray mass spectroscopy.Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.

P2860

Q24620186-F2BBA156-E3E7-456D-B9C8-B45CCD7661EA Q24647850-CABAF8D4-6A10-4DCE-897D-B5AA71BDBF86 Q24656049-5A7998FE-FDC2-4AC5-8FCA-A4E1AF70C44F Q24657799-A99B6CE1-D0C9-4452-989D-D65F7A4AAA0F Q24670395-6ED05BF9-8473-47D0-847A-CD6AB22B6E50 Q26747533-8FDD31B2-78A1-4034-B06D-EEB6B2F005B4 Q26765760-3765EA90-DFEB-4C0F-A5E8-EF303C32D31F Q26783956-54A24ACE-9817-4CF8-A5CB-9AF2D584DCDB Q26786474-8735D00A-6509-431D-A901-7C49431A8DE1 Q26786478-C5C0E58B-4E13-4C17-83EF-18C1F34E1815 Q26865131-DAB36652-21B9-4D73-A2E9-A261A7030C25 Q27313563-A896EB6C-DE6C-480E-A323-BFA15C2F8EC6 Q27686780-A256AD0D-CD04-4F4D-ACA9-A1FDA88F447D Q27686851-B3338643-EF09-44B2-BF13-447EE05E0376 Q28086830-B0697DF3-7202-4047-A413-5A2294FFC22D Q28200171-AC7C365E-C3E1-4A2F-A0C1-0C8407EE5FEA Q28252319-EC7815F1-872F-48F9-B116-4EC9D07BB971 Q28271125-CDE3E168-1A64-4C8E-AD3C-3FB788F2AE3D Q28284073-6C29100F-FE94-414E-BEE2-52EF7640D493 Q28480932-ACF37768-12AA-4E3C-82AE-D51A5F371880 Q28579681-0997C2F3-EC6D-4D5B-9166-18C2E8E7F80D Q30434994-295D0327-83F0-4136-B0B2-BE94E864E0D1 Q30493991-9FCAA0B3-F87E-429D-B20E-00B08DBF6C2D Q30574567-30606EAC-F143-4B93-9F70-202939554979 Q33628837-7D79A0E0-C89C-4132-A8B9-8BD6C04699F7 Q33699215-1C214DC7-0A38-4898-9E82-0689B489036B Q33719329-B0588AB8-5ABE-4BA0-80CA-00D4D71262D9 Q33751118-365590B1-A1C4-43A1-A61D-08302FC52952 Q33819204-B4F7ABD0-067D-455E-AD04-8364B06DDC0F Q33828435-D95271AE-47CB-4F39-9E2B-84918B67E3D4 Q34201476-DA74DFA8-D840-42DD-9680-694233BE7962 Q34402180-8B9234A6-026F-4EC0-BA78-3B2A63F49543 Q34438163-37E32B5A-D2E8-4FB8-A813-8C3F687CF27E Q34587990-61C558B5-8D89-413B-9871-BDE3BA95F5E1 Q34608846-21DAD707-367B-482B-8C8A-7A2E9A5F9B88 Q34612917-BE670323-F9CB-45D6-9E32-D9FA918C2E07 Q34637516-9CDD1F7E-9C8C-44D8-AE23-F357C0AB04E3 Q34644485-D87B8F3B-03D7-41C9-8D6A-E4E268F156C5 Q34659846-C3F95E94-3AAB-4F09-986E-29DA9F957FC0 Q34661844-C28A059F-7884-46BB-A6D2-DDB434F87702

P2860

Anandamide and vanilloid TRPV1 receptors

http://www.wikidata.org/entity/Q24672354

description

2003 nî lūn-bûn

@nan

2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Anandamide and vanilloid TRPV1 receptors

@ast

Anandamide and vanilloid TRPV1 receptors

@en

Anandamide and vanilloid TRPV1 receptors

@nl

type

label

Anandamide and vanilloid TRPV1 receptors

@ast

Anandamide and vanilloid TRPV1 receptors

@en

Anandamide and vanilloid TRPV1 receptors

@nl

prefLabel

Anandamide and vanilloid TRPV1 receptors

@ast

Anandamide and vanilloid TRPV1 receptors

@en

Anandamide and vanilloid TRPV1 receptors

@nl

P1433

Q24672354-A84E9531-BCBA-4109-9A74-A0C66ABCD0E3

P1476

Q24672354-EB07F8A4-98C8-4D00-875A-15D2CD8172FB

P2093

Q24672354-F0BCC812-E5B0-443A-9528-042C55B66D1A

P2860

Q24672354-01F68CA4-60DF-4734-AB53-CDB95B600A98

Q24672354-0652249A-B3C6-42EA-823B-405B54284994

Q24672354-07DE9389-26A6-4CC0-B0AE-A8F84AC99367

Q24672354-08330D79-3395-41D4-907C-B4BE54837C78

Q24672354-1238DFDD-0080-4486-BAD5-F13B940070C5

Q24672354-12DCDD65-4ACD-4F68-BDD3-CCEF7FF498D7

Q24672354-133F5544-918A-4E3C-994F-67C57344ECB8

Q24672354-1665A3F8-BC8C-4D66-B6EE-F314B609A15F

Q24672354-1A5542EA-FC58-42F7-8517-084881B6414E

Q24672354-1B5B1601-0DA7-471A-98CC-0607934B9B38

P304

Q24672354-AA7AC711-891C-465F-8346-603036028AAA

P31

Q24672354-47E5D22C-2133-4A6E-B0AB-1FBFB4A0168F

P3181

Q24672354-40F4B0EC-C320-4373-A45B-0AC3DA40BBAB

P356

Q24672354-C0F9F6B7-5589-418F-B9C5-6282FEF4794F

P407

Q24672354-98D0756E-C073-449C-B6AA-FED24C713B75

P433

Q24672354-1984BED2-7F5E-4642-AF04-6667CD98F8A1

P478

Q24672354-94FC1323-783B-42ED-B1B3-9DF791FC6C07

P577

Q24672354-135A0970-C5A0-4979-A0B5-5D03523E5C0D

P5875

Q24672354-7BCF269B-2CB3-4D2C-BEBE-870202B36EA6

P698

Q24672354-AE58B300-BA5D-4823-BE7B-58B080B87D16

P921

Q24672354-08B564C9-0B83-42DB-8DED-0C21E0C2DC94

Q24672354-CB2FCF2E-4801-458B-AB3C-5271B390E136

P932

Q24672354-37D1FC01-E4C7-46C2-86A5-402D671601A4

P3181

P356

P1433

British Journal of Pharmacology

P1476

Anandamide and vanilloid TRPV1 receptors

@en

P2093

Ruth A Ross

http://www.w3.org/2001/XMLSchema#string

P2860

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors.

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

Evidence against the presence of an anandamide transporter

Induction of vanilloid receptor channel activity by protein kinase C

Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances

CB(1) receptor antagonist SR141716A increases capsaicin-evoked release of Substance P from the adult mouse spinal cord

Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide

Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens

P304

790-801

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1652372

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.BJP.0705467

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

140

http://www.w3.org/2001/XMLSchema#string

P577

2003-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9074171

http://www.w3.org/2001/XMLSchema#string

P698

14517174

http://www.w3.org/2001/XMLSchema#string

P921

P932

1574087

http://www.w3.org/2001/XMLSchema#string